Access Statistics for Simona Gamba

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Audit publicity and tax compliance: a quasi-natural experiment 0 0 0 65 0 1 1 136
COVID-19: $R_0$ is lower where outbreak is larger 0 0 0 12 0 0 0 48
COVID-19: R0 is lower where outbreak is larger 0 0 0 29 1 2 4 123
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 0 0 2 154 5 9 19 402
Is Tax Compliance a Social Norm? A Field Experiment 0 0 0 251 2 3 8 679
Lies have long legs. Cheating, public scrutiny and loyalty in teams 1 1 1 44 5 5 7 164
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 0 5 16 0 2 22 38
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 0 1 22 1 3 12 54
Optimizing Tax Administration Policies with Machine Learning 0 1 2 266 3 12 17 704
R&D and market size: who benefits from orphan drug regulation? 0 0 0 76 1 4 7 201
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 0 1 3 25 5 9 16 78
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 0 26 2 8 9 138
The Impact of Social Pressure on Tax Compliance: a Field Experiment 0 0 1 89 9 11 13 139
The Italian Blitz: a natural experiment on audit publicity and tax compliance 0 0 0 67 4 4 7 95
The effect of Intellectual Property Rights on domestic innovation in the pharmaceutical sector 0 0 0 72 0 6 12 129
What exactly is public in a public good game? A lab-in-the-field experiment 1 1 3 157 2 6 14 372
When the two ends meet: an experiment on cooperation across the Italian North-South divide 0 0 3 95 12 17 26 171
Total Working Papers 2 4 21 1,466 52 102 194 3,671


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Audit Publicity and Tax Compliance: A Natural Experiment 0 0 1 17 0 4 5 91
Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly 0 0 0 6 3 6 10 42
COVID-19: R0 is lower where outbreak is larger 0 0 0 3 2 5 5 20
Lies have long legs cheating, peer scrutiny and loyalty in teams 0 0 0 4 0 1 2 24
Machine learning and the optimization of prediction-based policies 1 1 2 6 6 9 19 28
R&D and market size: Who benefits from orphan drug legislation? 0 0 0 4 3 4 8 36
R&D investments, financing constraints, exporting and productivity 0 0 1 57 1 3 7 169
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 1 2 20 2 7 13 121
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design 0 0 0 2 0 2 2 9
The impact of managed entry agreements on pharmaceutical prices 0 0 2 16 2 6 15 89
The impact of social pressure on tax compliance: A field experiment 0 1 3 27 1 2 5 129
When the two ends meet: an experiment on cooperation and social capital 0 0 1 6 4 7 11 37
Total Journal Articles 1 3 12 168 24 56 102 795


Statistics updated 2026-01-09